🇺🇸 FDA
Patent

US 6818622

Selective MMP inhibitors having reduced side-effects

expired A61KA61K38/55A61P

Quick answer

US patent 6818622 (Selective MMP inhibitors having reduced side-effects) held by Darwin Discovery Limited expires Mon Nov 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Darwin Discovery Limited
Grant date
Tue Nov 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K38/55, A61P, A61P19/02, A61P29/00